C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/64 (2006.01) A61K 38/17 (2006.01) A61K 38/36 (2006.01) A61K 38/48 (2006.01) A61P 7/00 (2006.01) C07K 1/22 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/745 (2006.01) C07K 16/36 (2006.01) C07K 16/40 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2143125
Methods for the generation of Ca2+ -independent antibodies against blood coagulation factors, employing an antibody selection strategy based on small peptides that are comprising target sequences for limited proteolysis. These antibodies, which substantially distinguish between intact and cleaved species of said haemostatic protein, provide novel tools for the isolation of intact haemostatic proteins. By virtue of the absence of cleavage products that usually are associated with side-effects or reduced efficacy, these intact proteins may serve as improved agents in therapeutic compositions for the treatment of haemostatic disorders.
Mertens Koenraad
Van Mourik Jan A.
Borden Ladner Gervais Llp
Stichting Centraal Laboratorium Van de Bloedtransfusiedienst Van
LandOfFree
Antibodies specific for a haemostatic protein, their use for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies specific for a haemostatic protein, their use for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies specific for a haemostatic protein, their use for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1556680